NASDAQ: WHWK Whitehawk Therapeutics, Inc. 10-Q

Whitehawk advances two ADC candidates into Phase 1 trials; cash drops $108M year-over-year

Filed May 7, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 8, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade WHWK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.